Free Trial
NYSEARCA:LABU

Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News

Direxion Daily S&P Biotech Bull 3x Shares logo
$78.72 -4.02 (-4.86%)
Closing price 09/12/2025 04:10 PM Eastern
Extended Trading
$79.14 +0.42 (+0.54%)
As of 09/12/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Key Stats

Today's Range
$78.63
$82.65
50-Day Range
$58.01
$82.74
52-Week Range
$32.55
$152.58
Volume
822,161 shs
Average Volume
1.68 million shs
Market Capitalization
$816.33 million
Assets Under Management
$666.31 million
Dividend Yield
0.41%
Net Expense Ratio
0.93%
Aggregate Rating
Moderate Buy

ETF Overview

Direxion Daily S&P Biotech Bull 3x Shares Expenses

TypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.51%0.53%
Other Expenses0.18%0.47%0.56%0.59%0.56%
Total Expense0.93%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.93%0.60%0.63%0.58%0.60%
Receive LABU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LABU ETF News Headlines

Direxion Daily S&P Biotech Bull 3X Shares - Markets Insider
Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008."tc pixel
Direxion Daily Semiconductor Bear 3X Shares rises 11.6%
See More Headlines

LABU ETF - Frequently Asked Questions

Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $90.00 at the beginning of the year. Since then, LABU stock has decreased by 12.5% and is now trading at $78.72.

Direxion Daily S&P Biotech Bull 3x Shares's stock reverse split on Monday, December 4th 2023.The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Top institutional shareholders of Direxion Daily S&P Biotech Bull 3x Shares include Squarepoint Ops LLC (1.55%), Squarepoint Ops LLC (1.55%), Jane Street Group LLC and Ethos Financial Group LLC (0.09%).

Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily S&P Biotech Bull 3x Shares
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:LABU
Inception Date
5/28/2015
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
142

Fund Statistics

Assets Under Management
$666.31 million
Average Daily Volume
$1.20 million
Discount/Premium
0.09%
Leveraged
3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
5,838
Put Options
3,457
Call Options
2,381
Short Interest
874,900 shs

Miscellaneous

Beta
3.00
Creation Unit
50,000
Creation Fee
$250.00
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Top 10 LABU Holdings

LABU Sector Exposure

LABU Industry Exposure


This page (NYSEARCA:LABU) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners